ArticleFrontiers in endocrinology2022

Real-world national trends and socio-economic factors preference of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in China.

Cao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.